Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

15.46
Delayed Data
As of Dec 09
 +0.02 / +0.13%
Today’s Change
13.77
Today|||52-Week Range
119.87
-84.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Operating ActivitiesNet Income / Starting Line-347.0M-372.9M-325.9M-1.2B
 
 
 
 
 
Depreciation602.5M746.8M751.0M698.9M
 
 
 
 
 
Total Other Cash Flow234.5M159.9M174.7M1.3B
 
 
 
 
 
Funds From Operations558.7M507.6M456.1M591.0M
 
 
 
 
 
Funds From/For Other Operating Expenses113.3M-50.2M42.5M58.9M
 
 
 
 
 
Net Cash Flow - Operating Activities445.4M557.8M413.6M532.1M
 
 
 
 
 
 
InvestingIncrease In Investments-47.2M0.00-1.4M21.2K
 
 
 
 
Decrease In Investments-111.8M0.0015.7M1.1M
 
 
 
 
Capital Expenditures-78.9M-62.3M-70.1M-51.8M
 
 
 
 
 
Fixed Asset Disposal--6.3M108.7M18.7M
 
 
 
 
Net Assets From Acquisitions -1.4B-48.7M-1.6M736.1K
 
 
 
 
 
Other Investing - Uses-20.2M0.000.000.00
 
 
Net Cash Flow Investing-1.5B-112.0M47.9M-69.6M
 
 
 
 
 
 
FinancingShort Term Borrowings-300.0K0.00309.7K-411.4K
 
 
 
 
Long Term Borrowings1.7B1.2B39.4M-18.5M
 
 
 
 
 
Long Term Debt Reduction-871.2M-425.6M-888.7M-635.8M
 
 
 
 
 
Net Proceeds Stock Sale66.1M800.0K-77.4K32.9M
 
 
 
 
 
Common Preferred Redeemed-24.7M0.000.000.00
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing33.7M0.000.000.00
 
 
Other Uses - Financing-23.1M535.7M57.9M44.9M
 
 
 
 
 
Net Cash Flow - Financing293.5M259.5M-906.9M-666.8M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-7.9M7.8M-4.4M3.1M
 
 
 
 
 
 
Net Change In Cash-771.8M705.3M-445.4M-204.2M